Cited by 23Cardiovascular Effects of ExerciseCardiomyopathy and Myosin StudiesCardiac electrophysiology and arrhythmias

Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy

Open access
Roudijk, Robert W., Verheul, Lisa, Bosman, Laurens P., Bourfiss, Mimount, Breur, Johannes M.P.J., Slieker, Martijn G., Blank, Andreas C., Dooijes, Dennis +9 more·2022·JACC: Clinical Electrophysiology

Abstract

Objectives The goal of this study was to describe characteristics, cascade screening results, and predictors of adverse outcome in pediatric-onset arrhythmogenic right ventricular cardiomyopathy (ARVC).Background Although ARVC is increasingly recognized in children, pediatric ARVC cohorts remain underrepresented in the literature.Methods This study included 12 probands with pediatric-onset ARVC (aged <18 years at diagnosis) and 68 pediatric relatives (aged <18 years at first evaluation) referred for cascade screening. ARVC diagnosis was based on 2010 Task Force Criteria. Clinical presentation, diagnostic testing, and outcomes (sustained ventricular tachycardia [VT]; heart failure) were ascertained. Predictors of adverse outcome were determined by using univariable logistic regression.Results Pediatric-onset ARVC was diagnosed in 12 probands and 12 (18%) relatives at a median age of 16.6 years (interquartile range: 13.8-17.4 years), whereas 12 (18%) relatives reached ARVC diagnosis as adults (median age, 22.0 years; interquartile range: 20.0-26.7 years). Sudden cardiac death/arrest was the first disease manifestation in 3 (25%) probands and 3 (4%) relatives. In patients without ARVC diagnosis at presentation (n = 61), electrocardiogram and Holter monitoring abnormalities occurred before development of imaging Task Force Criteria (7.3 ± 5.0 years vs 8.4 ± 5.0 years). Clinical course was characterized by sustained VT (91%) and heart failure (36%) in probands, which were rare in relatives (2% and 0%, respectively). Male sex (P < 0.01), T-wave inversion V 1-V 3 (P < 0.01), premature ventricular complexes/runs (P ≤ 0.01), and decrease in biventricular ejection fraction (P ≤ 0.01) were associated with VT occurrence.Conclusions Pediatric ARVC carries high arrhythmic risk, especially in probands. Disease progression is particularly observed on electrocardiogram or Holter monitoring. Arrhythmic events are associated with male sex, T-wave inversions, premature ventricular complexes/runs, and reduced biventricular ejection fraction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacep.2021.09.001

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Arrhythmogenic cardiomyopathy (ACM) is a genetically and phenotypically heterogeneous myocardial disorder characterized by progressive cardiomyocyte loss, immune cell infiltration, and fibro-fatty replacement of the ventricular myocardium.

    “Arrhythmogenic cardiomyopathy (ACM) is a genetically and phenotypically heterogeneous myocardial disorder characterized by progressive cardiomyocyte loss, immune cell infiltration, and fibro-fatty replacement of the ventricular myocardium [1,2,3,4,5].”

    From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [5]

    The opening passage (page not provided) describes ARVC as inherited and characterized by fibrofatty replacement predominantly in the right ventricular myocardium. It does not establish the broader description of ACM as genetically and phenotypically heterogeneous, or characterize the disease by progressive cardiomyocyte loss and immune cell infiltration. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [8]8. Te Riele A, James CA, Sawant AC, et al. Arrhythmogenic right ventricular dysplasia/car- diomyopathy in the pediatric population: clinical characterization and comparison with adult-onset disease. J Am Coll Cardiol EP. 2015;1:551-560.
  2. [17]17. Cadrin-Tourigny J, Bosman LP, Nozza A, et al. A new prediction model for ventricular arrhyth- mias in arrhythmogenic right ventricular cardio- myopathy. Eur Heart J. 2019;40:1850-1858.

Cited by

Sorted by citations

Authors
Roudijk, R. W., Verheul, L., Bosman, L. P., Bourfiss, M., Breur, J. M. P. J., Slieker, M. G., Blank, A. C., Dooijes, D., van der Heijden, J. F., van den Heuvel, F., Clur, S.-A., Udink ten Cate, F. E. A., van den Berg, M. P., Wilde, A. A. M., Asselbergs, F. W., Peter van Tintelen, J., & te Riele, A. S. J. M.
Affiliations
  • University Medical Center Utrecht (NL)
  • Wilhelmina Children's Hospital (NL)
  • Utrecht University (NL)
  • Emma Kinderziekenhuis (NL)
  • Amsterdam University Medical Centers (NL)
Venue
JACC: Clinical Electrophysiology
Publisher
Elsevier BV
Published
2022-03
Volume
8
Issue
3
Pages
306-318
ISSN
2405-500X (ISSN-L)
OpenAlex
W4200070568
Cited by
23
References
38
Citations by year
2026: 6 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 5
FWCI
2.20
Type
journal article
Language
en
Open access
Locations
  • JACC. Clinical electrophysiology (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
  • Pure Amsterdam UMC (acceptedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • UCL Discovery (University College London) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
Funders
  • NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
  • National Institute for Health and Care Research
  • University College London
  • Universitair Medisch Centrum Utrecht
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
arrhythmogenic right ventricular cardiomyopathy, sustained ventricular tachycardia, sudden cardiac death, heart failure, T-wave inversion, premature ventricular contractions, Task Force Criteria, disease progression, male sex
MeSH terms
Adolescent, Adult, Arrhythmias, Cardiac, Child, Electrocardiography, Follow-Up Studies, Heart Arrest, Heart Failure, Humans, Male, Death, Sudden, Cardiac, Tachycardia, Ventricular, Arrhythmogenic Right Ventricular Dysplasia, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review